<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> development relies on a variety of mechanisms that facilitate <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> despite the presence of a functioning immune system, employing different mechanisms to escape immune rejection </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> may eliminate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating lymphocytes and suppress anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> immune responses, a process called "<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> counterattack," based on activation-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> via the FAS/FAS-ligand system </plain></SENT>
<SENT sid="2" pm="."><plain>To overcome this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-cell survival strategy, we examined the hypothesis that the sensitivity of FAS mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of Jurkat-T-cells can be suppressed by FLIP transfection of Jurkat-T-cells </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Jurkat-T-cells were transfected with the FLICE-inhibitory protein FLIP in order to bestow them with a resistance to FAS-receptor-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>FLIP-transfected and non-transfected Jurkat-T-cells were grown in coincubation with SW620 cells and the rates of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> measured via FACS-analysis of Annexin-V </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: First, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-counterattack described in the literature was confirmed </plain></SENT>
<SENT sid="6" pm="."><plain>About 20% of Jurkat-T-Cells underwent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in coculture with SW620 cells </plain></SENT>
<SENT sid="7" pm="."><plain>After coincubation of SW620 cells with FLIP transfected Jurkat-T-cells the apoptotic rate was significant reduced at levels below 4% </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Transfection of Jurkat-T-cells with FLIP reduces the sensitivity of Jurkat-T-cells to FAS-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and may lead to an improved capability to antagonize the inherent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> survival strategy of SW620 cells </plain></SENT>
</text></document>